Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-11 Purchase |
2022-03-15 6:30 pm |
Aeglea BioTherapeutics Inc. | AGLE | Alspaugh Jonathan Chief Financial Officer |
75,000 | $2.08 | $156,000 | 165,372 (Direct) |
View |
| 2021-12-09 Purchase |
2021-12-13 8:37 pm |
Aeglea BioTherapeutics Inc. | AGLE | Alspaugh Jonathan Chief Financial Officer |
50,000 | $3.72 | $186,000 | 90,372 (Direct) |
View |
| 2021-08-16 Purchase |
2021-08-18 5:21 pm |
Aeglea BioTherapeutics Inc. | AGLE | Alspaugh Jonathan Chief Financial Officer |
40,372 | $6.506 | $262,660 | 40,372 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-22 Option Award |
2023-06-30 4:34 pm |
N/A 2033-06-22 |
Aeglea BioTherapeutics Inc. | AGLE | Alspaugh Jonathan President and CFO |
19,787,969 | $0 | 19,787,969 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-24 6:20 pm |
N/A 2033-02-22 |
Aeglea BioTherapeutics Inc. | AGLE | Alspaugh Jonathan Chief Financial Officer |
640,000 | $0 | 640,000 (Direct) |
View |
| 2022-08-23 Option Award |
2022-08-25 7:34 pm |
N/A 2032-08-22 |
Aeglea BioTherapeutics Inc. | AGLE | Alspaugh Jonathan Chief Financial Officer |
130,000 | $0 | 130,000 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 4:50 pm |
N/A 2032-02-16 |
Aeglea BioTherapeutics Inc. | AGLE | Alspaugh Jonathan Chief Financial Officer |
170,000 | $0 | 170,000 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 5:12 pm |
N/A 2031-07-05 |
Aeglea BioTherapeutics Inc. | AGLE | Alspaugh Jonathan Chief Financial Officer |
160,000 | $0 | 160,000 (Direct) |
View |